Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Response to Comment on Inciden...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Response to Comment on Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Bibliographic Details
Main Authors: Andrew H. Lipsky, Jay N. Lozier, Adrian Wiestner
Format: Article
Language:English
Published: Ferrata Storti Foundation 2016-03-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/7665
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/7665

Similar Items

  • Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib
    by: Andrew H. Lipsky, et al.
    Published: (2015-12-01)
  • Comment on Lipsky et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib
    by: Constantine S. Tam, et al.
    Published: (2016-03-01)
  • Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib
    by: Candida Vitale, et al.
    Published: (2016-06-01)
  • The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
    by: Dan A. Landau, et al.
    Published: (2017-12-01)
  • Real-World Clinical Outcomes and Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Single-Center Retrospective Study
    by: Ana-Maria Moldovianu, et al.
    Published: (2023-02-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs